Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andreas Bergmann

Showing results (201-210 of 254) with videos related to

Pageof 26
Sort By:
Frontiers in Medicine|December 19, 2022
Effects of enrichment strategies on outcome of adrecizumab treatment in septic shock: <i>Post-hoc</i> analyses of the phase II adrenomedullin and outcome in septic shock 2 trialDirk van Lier, Adrien Picod, Gernot Marx, et al.
Disease Models & Mechanisms|June 18, 2017
(CCUG)<sub>n</sub> RNA toxicity in a <i>Drosophila</i> model of myotonic dystrophy type 2 (DM2) activates apoptosisVildan Betul Yenigun, Mario Sirito, Alla Amcheslavky, et al.
Biomolecules|August 16, 2020
Targeting Endothelial Dysfunction in Eight Extreme-Critically Ill Patients with COVID-19 Using the Anti-Adrenomedullin Antibody Adrecizumab (HAM8101)Mahir Karakas, Dominik Jarczak, Martin Becker, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 15, 2015
Stable Peptide of the Endogenous Opioid Enkephalin Precursor and Breast Cancer RiskOlle Melander, Marju Orho-Melander, Jonas Manjer, et al.
European Journal of Heart Failure|January 26, 2010
The predictive value of stable precursor fragments of vasoactive peptides in patients with chronic heart failure: data from the GISSI-heart failure (GISSI-HF) trialSerge Masson, Roberto Latini, Emanuele Carbonieri, et al.
Circulation|April 11, 2007
C-terminal provasopressin (copeptin) as a novel and prognostic marker in acute myocardial infarction: Leicester Acute Myocardial Infarction Peptide (LAMP) studySohail Q Khan, Onkar S Dhillon, Russell J O'Brien, et al.
Stroke|May 29, 2010
Prognostic value of copeptin: one-year outcome in patients with acute strokeSandrine A Urwyler, Philipp Schuetz, Felix Fluri, et al.
Biological Psychiatry|April 5, 2011
Antihypertensive therapy is associated with reduced rate of conversion to Alzheimer's disease in midregional proatrial natriuretic peptide stratified subjects with mild cognitive impairmentPhiline Schneider, Katharina Buerger, Stefan Teipel, et al.
Critical Care (London, England)|July 25, 2009
Midregional pro-adrenomedullin in addition to b-type natriuretic peptides in the risk stratification of patients with acute dyspnea: an observational studyMihael Potocki, Tobias Breidthardt, Tobias Reichlin, et al.
European Journal of Clinical Investigation|July 17, 2018
Proenkephalin for the early detection of acute kidney injury in hospitalized patients with chronic kidney diseaseTobias Breidthardt, Cedric Jaeger, Andreas Christ, et al.
Pageof 26

Showing results (201-210 of 254) with videos related to

Sort By:
Pageof 26
Frontiers in Medicine|December 19, 2022
Effects of enrichment strategies on outcome of adrecizumab treatment in septic shock: <i>Post-hoc</i> analyses of the phase II adrenomedullin and outcome in septic shock 2 trialDirk van Lier, Adrien Picod, Gernot Marx, et al.
Disease Models & Mechanisms|June 18, 2017
(CCUG)<sub>n</sub> RNA toxicity in a <i>Drosophila</i> model of myotonic dystrophy type 2 (DM2) activates apoptosisVildan Betul Yenigun, Mario Sirito, Alla Amcheslavky, et al.
Biomolecules|August 16, 2020
Targeting Endothelial Dysfunction in Eight Extreme-Critically Ill Patients with COVID-19 Using the Anti-Adrenomedullin Antibody Adrecizumab (HAM8101)Mahir Karakas, Dominik Jarczak, Martin Becker, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 15, 2015
Stable Peptide of the Endogenous Opioid Enkephalin Precursor and Breast Cancer RiskOlle Melander, Marju Orho-Melander, Jonas Manjer, et al.
European Journal of Heart Failure|January 26, 2010
The predictive value of stable precursor fragments of vasoactive peptides in patients with chronic heart failure: data from the GISSI-heart failure (GISSI-HF) trialSerge Masson, Roberto Latini, Emanuele Carbonieri, et al.
Circulation|April 11, 2007
C-terminal provasopressin (copeptin) as a novel and prognostic marker in acute myocardial infarction: Leicester Acute Myocardial Infarction Peptide (LAMP) studySohail Q Khan, Onkar S Dhillon, Russell J O'Brien, et al.
Stroke|May 29, 2010
Prognostic value of copeptin: one-year outcome in patients with acute strokeSandrine A Urwyler, Philipp Schuetz, Felix Fluri, et al.
Biological Psychiatry|April 5, 2011
Antihypertensive therapy is associated with reduced rate of conversion to Alzheimer's disease in midregional proatrial natriuretic peptide stratified subjects with mild cognitive impairmentPhiline Schneider, Katharina Buerger, Stefan Teipel, et al.
Critical Care (London, England)|July 25, 2009
Midregional pro-adrenomedullin in addition to b-type natriuretic peptides in the risk stratification of patients with acute dyspnea: an observational studyMihael Potocki, Tobias Breidthardt, Tobias Reichlin, et al.
European Journal of Clinical Investigation|July 17, 2018
Proenkephalin for the early detection of acute kidney injury in hospitalized patients with chronic kidney diseaseTobias Breidthardt, Cedric Jaeger, Andreas Christ, et al.
Pageof 26